Back

Gene editing: can CRISPR cure ATTR?

28 August 2026 (09:27 - 09:45)
Organised by: Logo
Congress Presentation Part of: Frontiers in amyloid heart disease: from treatment to cure Cardiac Amyloidosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Julian Gillmore

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Why amyloid heart disease became treatable: TTR biology and the therapeutic ladder
Doctor L. Obici (Pavia, IT)
Slides Video
Presentation thumbnail
Diagnosis and the window for cure: imaging, biomarkers, and gene-carrier screening
Doctor E. Gonzalez Lopez (Madrid, ES)
Slides Video
Presentation thumbnail
Silencing TTR: siRNA and antisense in the clinic
Doctor M. Maurer (New York, US)
Slides Video
Presentation thumbnail
Clearing deposited amyloid: antibody-based depletion
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides Video

Access the full session

Session thumbnail
Frontiers in amyloid heart disease: from treatment to cure
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 09:27 CET
You may be interested in
thumbnail
Congress Presentation
In vivo gene editing with YOLT-201 for transthyretin amyloid cardiomyopathy – an open-label, first-in-human clinical trial
31 August 2026
thumbnail
Congress Presentation
Genetic therapy to cure the heart: inherited cardiomyopathies
31 August 2024
thumbnail
Congress Presentation
CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy: treatment effect in hereditary vs. wild-type disease
17 May 2025
thumbnail
Congress Presentation
Amyloidosis
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources